Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular diso
After referring to the launch of its type 2 diabetes therapy Mounjaro as viral e
Bill Anderson's replacement as chief executive of Roche Pharmaceuticals has been announced, with head of global product strategy Teresa Graham stepping up into the role.
Telehealth and discount medicines provider GoodRx has been ordered to pay a $1.5 million fine by the US authorities for sharing its customers' sensitive health information
Industry-dedicated summit focused on advancing the best-in-class kinase inhibitor products
The 5th Annual Cell Engager Summit is back in Boston, MA this year
Bringing Next Generation RNA Therapies to Patients Fast
PharmStars Accelerator Open for Applications